These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Antibodies in addition to statin therapy lowers LDL cholesterol]. Bossenmayer S Dtsch Med Wochenschr; 2012 Sep; 137(36):1728. PubMed ID: 23281534 [No Abstract] [Full Text] [Related]
9. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476 [TBL] [Abstract][Full Text] [Related]
10. Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution. Davidson MH Nat Rev Cardiol; 2013 Nov; 10(11):618-9. PubMed ID: 24019032 [No Abstract] [Full Text] [Related]
11. Beyond anti-PCSK9 therapies: the potential role of resistin inhibitors. Sahebkar A Nat Rev Cardiol; 2014 Jan; 11(1):12. PubMed ID: 24217159 [No Abstract] [Full Text] [Related]
12. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial. Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602 [TBL] [Abstract][Full Text] [Related]
13. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
14. Ezetimibe plus simvastatin cardiovascular outcomes study program. Padial LR Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615 [No Abstract] [Full Text] [Related]
16. Is there a problem with ezetimibe or just ENHANCEd hype? Whayne TF Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445 [No Abstract] [Full Text] [Related]
17. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ; Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231 [TBL] [Abstract][Full Text] [Related]
18. ENHANCE results: a surrogate trial that impacts beyond size and scope. Cardiovasc J Afr; 2008; 19(3):166-8. PubMed ID: 18568183 [No Abstract] [Full Text] [Related]
19. Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care. Martin AC; Coakley J; Forbes DA; Sullivan DR; Watts GF J Paediatr Child Health; 2013 Apr; 49(4):E263-72. PubMed ID: 23252991 [TBL] [Abstract][Full Text] [Related]
20. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"]. MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234 [No Abstract] [Full Text] [Related] [Next] [New Search]